SAVANNAH SANCHEZ: Open Payments
NPI 1598153751 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,556 in 289 payments from 25 companies in 2025. Trend: 2023 $3,920 · 2024 $3,510 · 2025 $4,556
Food & beverage: $4,556
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 59 | $787 |
| Neurocrine BioSciences, Inc. | 64 | $686 |
| ACADIA Pharmaceuticals Inc | 34 | $627 |
| PFIZER INC. | 37 | $377 |
| Biogen, Inc. | 10 | $237 |
| Merz Pharmaceuticals, LLC | 10 | $225 |
| Lundbeck LLC | 10 | $195 |
| ARGENX US, INC. | 8 | $158 |
| Otsuka America Pharmaceutical, Inc. | 5 | $134 |
| GENZYME CORPORATION | 4 | $117 |
Products named: INGREZZA, NUPLAZID, QULIPTA, NURTEC ODT, UBRELVY, Xeomin, REXULTI, BOTOX.
Industry payments across LA — which companies pay providers there.
